The impact of neuropathic pain on health-related quality of life: review and implications.
about
Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trialsNon-pharmacological interventions for chronic pain in people with spinal cord injuryOpioids for neuropathic painNon-pharmacological interventions for chronic pain in people with spinal cord injuryRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateAcetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trialsAdenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in ratsAssociation between depression and neuropathy in people with type 2 diabetes: a meta-analysis.Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Prevalence of neuropathic pain after radical sacral chordoma resection: an observational cohort study with 10-year follow-up.Relationship of depression, disability, and family caregiver attitudes to the quality of life of Kuwaiti persons with multiple sclerosis: a controlled study.Resilience and Vulnerability to Pain and Inflammation in the Hippocampus.Treatment considerations for elderly and frail patients with neuropathic painTreatment considerations for patients with neuropathic pain and other medical comorbidities.Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.Central neuropathic pain after cerebral venous thrombosis is not so uncommon: an observational study.Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.Pain intensity and its association with negative mood States in patients with spinal cord injury.Habituation to experimentally induced electrical pain during voluntary-breathing controlled electrical stimulation (BreEStim)Acupuncture and chiropractic care for chronic pain in an integrated health plan: a mixed methods study.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Transcranial Direct Current Stimulation in Neuropathic PainEstimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?A classification of chronic pain for ICD-11.Therapy using implanted organic bioelectronics.Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.Impact of locomotion training with a neurologic controlled hybrid assistive limb (HAL) exoskeleton on neuropathic pain and health related quality of life (HRQoL) in chronic SCI: a case study (.).Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer.Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster - a case series.Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States.Consideration of chronic pain in trials to promote physical activity for diabetes: a systematic review of randomized controlled trials.The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica.Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodentsCombined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in miceNeuropathic pain: a personal case reflection on a critical incident.Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy.Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy.2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.
P2860
Q21261358-EA3BCCCB-13D0-412D-995F-99A43DB89985Q24187769-2828050C-F01D-490C-91C2-46DF79A171BFQ24200179-D7A2D9E9-8214-4A50-84CC-3A6282CF5203Q24235877-8AB247BB-4416-411F-BB6B-7B8B551D8C80Q24616897-561C8477-3AD1-4064-8845-0488EF1B0286Q26995876-5F7F218D-ABE4-4241-BEA1-9D3FC9DA588AQ28581388-B245A29D-A821-4B68-B4AF-C4D6F8598026Q30251984-D98961C2-98A9-438B-AC52-1A100CB5B08AQ30537158-A2856B37-102C-4B27-80C9-B7D506FF0E15Q33275388-1B0FC0FF-8868-4BF7-ACE7-841F618C8F83Q33299391-1597D9F5-7861-4817-AB34-A65F17357DF8Q33624442-5E0FDC43-A081-49D3-851A-03F55AE07180Q33747265-9732676B-42DA-4CC3-B24E-359360B84969Q33747271-51A84D82-9C56-4A2D-9234-FFFEA348F407Q33751809-DCDDA08B-F7EE-4ABB-B3D3-E9E891D217A5Q33810343-73B612DF-1EDB-47D1-B24E-90329269AD35Q33937485-AD1FACD7-15EC-48EA-9AEE-C61637231184Q33938295-2FC5DBE6-9D57-49DD-8A29-C66893CF3F41Q34083505-A090C051-DA02-436D-AED2-5C7563FE19B8Q34083886-5A25D7EF-5D87-41CE-90E5-AA4E77F6E19EQ34110857-A52353F9-7AAE-436A-BD82-312E0FEFD51DQ34320994-BF0034CC-916D-498C-BDB5-74AD4B1F7D5DQ34451586-75D07567-1E4C-40A6-948D-70D67F6E31A9Q34470394-997BFE38-9CDB-4F93-A52C-B87023601DB1Q34502830-9C25C826-D35E-4B6A-8F00-CE44E2EE1831Q34640959-1BCE6CE3-A4F0-44E7-A6E1-B63F6E667094Q34666193-F38B3B36-C068-421A-AA59-67CC7A88BC44Q34762806-BE963959-31DC-459B-AF4F-B0C10C3626E9Q34783788-2D97AFEB-748A-4450-B70D-24C3466D3DE3Q34785937-8C7A197B-DF80-4A0F-8965-AC65C71A31F6Q34795362-7E0CEA57-3C86-45E1-84D3-5219A48A3228Q34936623-926E986D-5878-4693-8BE4-730460131578Q34949720-A5847054-D58F-49E4-95B6-091C083A8A71Q35155806-F712722E-6D7C-477D-8468-589FDBAFEF03Q35223920-6EA982AD-FF68-4DF9-B6EF-3F799B2BDD6EQ35245083-13EAE8CD-A221-4DBA-A359-86DC3FC88A62Q35565643-8699467C-26AB-4250-9DE0-E75D5F82DBEBQ35584564-F9031EF1-945B-4E43-8C22-50301C5FA68EQ35619182-D8419045-7389-4C44-8A5A-41555C252A48Q35685828-BA33638E-8299-4275-BFCE-7F68057D183A
P2860
The impact of neuropathic pain on health-related quality of life: review and implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The impact of neuropathic pain ...... life: review and implications.
@en
type
label
The impact of neuropathic pain ...... life: review and implications.
@en
prefLabel
The impact of neuropathic pain ...... life: review and implications.
@en
P2093
P1433
P1476
The impact of neuropathic pain ...... life: review and implications.
@en
P2093
Marci J Chodroff
Mark P Jensen
Robert H Dworkin
P304
P356
10.1212/01.WNL.0000259085.61898.9E
P407
P577
2007-04-01T00:00:00Z